BioGaia AB Statistics

Total Valuation

BioGaia AB has a market cap or net worth of SEK 10.19 billion. The enterprise value is 8.99 billion.

Market Cap	10.19B
Enterprise Value	8.99B

Important Dates

The next estimated earnings date is Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	May 8, 2025

Share Statistics

BioGaia AB has 101.16 million shares outstanding. The number of shares has increased by 0.09% in one year.

Current Share Class	n/a
Shares Outstanding	101.16M
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	1.74%
Owned by Institutions (%)	44.79%
Float	77.73M

Valuation Ratios

The trailing PE ratio is 28.96 and the forward PE ratio is 25.89.

PE Ratio	28.96
Forward PE	25.89
PS Ratio	7.16
PB Ratio	5.91
P/TBV Ratio	6.58
P/FCF Ratio	28.34
P/OCF Ratio	27.30
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.50, with an EV/FCF ratio of 25.02.

EV / Earnings	25.59
EV / Sales	6.32
EV / EBITDA	18.50
EV / EBIT	19.53
EV / FCF	25.02

Financial Position

The company has a current ratio of 7.81, with a Debt / Equity ratio of 0.02.

Current Ratio	7.81
Quick Ratio	7.01
Debt / Equity	0.02
Debt / EBITDA	0.06
Debt / FCF	0.08
Interest Coverage	318.91

Financial Efficiency

Return on equity (ROE) is 18.72% and return on invested capital (ROIC) is 15.07%.

Return on Equity (ROE)	18.72%
Return on Assets (ROA)	13.18%
Return on Invested Capital (ROIC)	15.07%
Return on Capital Employed (ROCE)	25.19%
Revenue Per Employee	6.32M
Profits Per Employee	1.56M
Employee Count	225
Asset Turnover	0.65
Inventory Turnover	2.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.08% in the last 52 weeks. The beta is 0.71, so BioGaia AB's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-14.08%
50-Day Moving Average	114.36
200-Day Moving Average	114.68
Relative Strength Index (RSI)	39.47
Average Volume (20 Days)	164,117

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioGaia AB had revenue of SEK 1.42 billion and earned 351.39 million in profits. Earnings per share was 3.48.

Revenue	1.42B
Gross Profit	1.03B
Operating Income	460.51M
Pretax Income	447.82M
Net Income	351.39M
EBITDA	477.17M
EBIT	460.51M
Earnings Per Share (EPS)	3.48

Full Income Statement

Balance Sheet

The company has 1.22 billion in cash and 29.48 million in debt, giving a net cash position of 1.19 billion or 11.81 per share.

Cash & Cash Equivalents	1.22B
Total Debt	29.48M
Net Cash	1.19B
Net Cash Per Share	11.81
Equity (Book Value)	1.72B
Book Value Per Share	17.04
Working Capital	1.40B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 373.22 million and capital expenditures -13.76 million, giving a free cash flow of 359.46 million.

Operating Cash Flow	373.22M
Capital Expenditures	-13.76M
Free Cash Flow	359.46M
FCF Per Share	3.55

Full Cash Flow Statement

Margins

Gross margin is 72.45%, with operating and profit margins of 32.37% and 24.70%.

Gross Margin	72.45%
Operating Margin	32.37%
Pretax Margin	31.48%
Profit Margin	24.70%
EBITDA Margin	33.54%
EBIT Margin	32.37%
FCF Margin	25.27%

Dividends & Yields

This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 6.77%.

Dividend Per Share	6.90
Dividend Yield	6.77%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	54.60%
Buyback Yield	-0.09%
Shareholder Yield	6.68%
Earnings Yield	3.45%
FCF Yield	3.53%

Dividend Details

Stock Splits

The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.

Last Split Date	May 18, 2022
Split Type	Forward
Split Ratio	5

Scores

BioGaia AB has an Altman Z-Score of 25.58.

Altman Z-Score	25.58
Piotroski F-Score	n/a